1. Home
  2. |Insights
  3. |FDLI's Introduction to Drug Law and Regulation Conference

FDLI's Introduction to Drug Law and Regulation Conference

Event | 02.17.10 - 02.18.10, 12:00 AM UTC - 12:00 AM UTC

This is the premier course to help you and your organization understand FDA regulations for drug products. By attending this two day program, you will learn the essential elements of the laws and regulations that affect you in the drug industry. From the definition of “drug” to the different regulatory schemes for over-the-counter (OTC) and prescription (Rx) drugs, this meeting walks you through the major statutory provisions and regulations, and helps you develop a clearer understanding of how they work. You will receive a broad overview of FDA, the history of drug regulation, and details on specific areas of drug regulation. Additionally, you will examine FDA’s role in managing the drug approval process and how that process governs competition between branded and generic drugs. This program will help you think like an experienced drug professional. You will become more familiar with many of the acronyms used in the drug arena, such as, ANDA, IND, NDA, PDUFA and others. Further, you will gain a clearer understanding of how FDA enforces and implements the laws handed down by Congress. You will learn how all of these provisions and regulations affect what you do every day. This program will also cover the latest topics and important new developments affecting the drug industry, including prescription drug imports, risk management, OTC switches, Hatch-Waxman reform, and more.

Jen Schlosser and April Ross are attending this conference.

For more information, please visit these areas: Mass Tort, Product, and Consumer Litigation, Product Risk Management

Insights

Event | 05.09.24

Banking Cryptocurrency Companies After Crypto Winter

Please join us for an insightful panel discussion on the intricate dynamics between banks and cryptocurrency companies, especially in the aftermath of the challenges posed by the so-called Crypto Winter. Our panelists will delve into various pivotal topics, including the challenges faced by both crypto companies and banks and the considerations that drive these partnerships, including crucial aspects of anti-money laundering and sanctions risks.